This research was undertaken after approval from the Leeds East National Research Ethic Committee and informed written consent was obtained from all patients and healthy donors enrolled in the study. Femoral heads were obtained from patients undergoing total hip arthroplasty for primary OA (n = 26). Healthy iliac crest (IC) bone (n = 11) and femoral heads from fragility neck of femur fracture (NFF) patients (n = 3) were used as controls. Iliac crest biopsies were collected from patients undergoing orthopaedic surgery for metal removal following previous fracture, who were otherwise healthy. All bone samples were collected and processed on the day of the surgery and are detailed in the Supplementary Table S1 , available at Rheumatology online. Bone-resident MSCs were extracted by 4-h enzymatic digestion [8 (link)] and cell sorting [12 (link), 13 (link)]. Following digestion, the bone fragments were rigorously washed four times in large volumes of PBS using a method modified from Pathak et al. [14 (link)] to remove all residual cellular material from the bone surface. Osteocyte-enriched bone fragments were next homogenized in lysis buffer (guanidine isothiocyanate solution with 0.4% sodium citrate, 1% N-lauryl sarcosine and 0.5% β-mercaptoethanol) and RNA was precipitated with isopropanol and DNase treated (Invitrogen, Fisher Scientific, Leicestershire, UK). Total RNA from FACS-purified CD45-CD271+ MSCs and control CD45+CD271- haematopoietic-lineage cells [12 (link)] was extracted using the Single-Cell RNA Extraction kit (Norgen Biotek, Geneflow, Lichfield, UK) and on-column DNase (Applied Biosystems, Foster City, California, USA) treated. cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, California, USA). qPCR was performed on a QuantStudio7Flex Real-Time PCR System (Applied Biosystems) and gene expression levels normalized relative to housekeeping gene HPRT1. The TaqMan probes for the genes of interest are detailed in Supplementary Table S2 , available at Rheumatology online, all from Thermo Fisher. To evaluate multipotentiality, FACS-purified CD45-CD271+ were culture-expanded and differentiated towards osteogenic, adipogenic and chondrogenic lineages as described previously [8 (link), 12 (link)].
>
Chemicals & Drugs
>
Organic Chemical
>
CD-271
CD-271
CD-271, also known as nerve growth factor receptor (NGFR), is a cell surface receptor that plays a crucial role in the development and survival of nerve cells.
This receptor is expressed in various tissues, including the nervous system, and is involved in the signaling pathways that regulate neuronal differentiation, axon growth, and neuroprotection.
CD-271 is an important target for research in the fields of neuroscience, neurodegenerative disorders, and regenerative medicine.
The PubCompare.ai platform provides a powerful AI-driven tool to optimize CD-271 research protocols, enabling scientists to easily locate relevant protocols from literature, pre-prints, and patents, and leverage AI-comparisons to identify the best approaches for their studies.
This seamless optimization tool empowers researchers to accelerate their CD-271 research and drive breakthroughs in understanding the biology and therapeutic potential of this key receptor.
This receptor is expressed in various tissues, including the nervous system, and is involved in the signaling pathways that regulate neuronal differentiation, axon growth, and neuroprotection.
CD-271 is an important target for research in the fields of neuroscience, neurodegenerative disorders, and regenerative medicine.
The PubCompare.ai platform provides a powerful AI-driven tool to optimize CD-271 research protocols, enabling scientists to easily locate relevant protocols from literature, pre-prints, and patents, and leverage AI-comparisons to identify the best approaches for their studies.
This seamless optimization tool empowers researchers to accelerate their CD-271 research and drive breakthroughs in understanding the biology and therapeutic potential of this key receptor.
Most cited protocols related to «CD-271»
2-Mercaptoethanol
Adipogenesis
Biopsy
Bones
Buffers
CD-271
Cells
Chondrogenesis
Degenerative Arthritides
Deoxyribonuclease I
Digestion
DNA, Complementary
Donors
Enzymes
Ethics Committees
Femoral Neck Fractures
Femur Heads
Fracture, Bone
Gene Expression
Genes
Genes, Housekeeping
guanidine isothiocyanate
Hematopoietic System
Iliac Crest
Isopropyl Alcohol
Metals
Orthopedic Surgical Procedures
Osteocytes
Osteogenesis
Patients
Reverse Transcription
Sarcosine
Sodium Citrate
Surgery, Day
Total Hip Arthroplasty
Antibodies
Breast
Cadherins
CD-271
CD44 protein, human
CDH1 protein, human
Cell Nucleus
Cells
Clone Cells
Cytokeratin
Detergents
Endothelial Protein C Receptor
Epithelial Cells
Flow Cytometry
Fluorescein-5-isothiocyanate
Formalin
Furuncles
Goat
HOE 33342
Immunoglobulin Isotypes
ITGA6 protein, human
Molecular Probes
Mus
PROCR protein, human
Progressive Encephalomyelitis with Rigidity
Serum
Stem Cells
TACSTD1 protein, human
Vimentin
TCR constructs were subcloned into a pCCLc-MND-based lentiviral vector in the format TCRα-F2A-TCRβ-P2A-Myc271. Myc271 is a novel chimeric transduction marker comprising the transmembrane and truncated extracellular domains of CD271(LNGFR) fused to an extracellular cMyc epitope tag. Lentiviral vectors were prepared from 293T producer cells. One day prior to transfection, 1 x 106 293T cells/well were plated on 6-well plates. In 100 μL PBS, added 1 μg TCR lentivector, 1 μg pCMV-R8.2 (gag-pol helper plasmid), 0.2 μg pCAGGS-VSVG (pseudotyping helper plasmid), and 6.6 μL polyethyleneimine transfection reagent (Sigma) and incubated for 10 min. Fresh 2 mL media was replaced on plated 293T, and then transfection mix was added to cells. 48 hr following transfection, Jurkat T cells (10 (Johnson et al., 2009 (link)) cells/well in 250 μLC10) were added on a 24-well plate and 250 μL filtered (0.45 μm) viral supernatant was added to cells to initiate transduction. After 60–72 hr of transduction, Jurkats were assayed for TCR surface expression and function. To test for surface expression, cells were rinsed and stained with fluorescent antibodies and pMHC multimers in FACS buffer, and analyzed by flow cytometry. Dead cells were excluded from analysis using 7-AAD. To test for function, unselected Jurkat T cells were co-incubated in a 96-well plate at a 1:1 ratio with K562 cells stably expressing control or cognate peptide-MHC single chain trimers. After 48 hr of coincubation, the supernatant was tested for secreted interleukin-2 with a commercial ELISA kit according to the manufacturer’s protocol (BD, Franklin Lakes, NJ).
7-aminoactinomycin D
Antigen T Cell Receptor, beta Chain
Buffers
CD-271
Cells
Chimera
Cloning Vectors
Enzyme-Linked Immunosorbent Assay
Epitopes
Flow Cytometry
Fluorescent Antibody Technique
HEK293 Cells
Interleukin-2
Jurkat Cells
K562 Cells
Peptides
Plasmids
Polyethyleneimine
Transfection
A CFU‐F assay was performed as described previously 11 , with a minor modification using methylene blue, before scoring was performed in a blinded manner. MSC expansion was used to measure MSC proliferation rates and to produce a sufficient number of cells for trilineage differentiation assays and gene expression analysis. MSCs were expanded in StemMACS MSC Expansion Media after preenrichment using CD271 MACSelect MicroBeads (both from Miltenyi Biotec), and culture population doublings were calculated as previously described 20 . MSCs from the bone of healthy controls and patients with OP were expanded similarly following their enzymatic release from bone 11 .
Biological Assay
Bones
CD-271
Enzymes
Gene Expression Profiling
Methylene Blue
Microspheres
Patients
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Biological Assay
Caspase-7
Caspase 3
CD-271
Cells
Colorimetry
Mus
Serum
Streptomycin
Most recents protocols related to «CD-271»
Cells in suspension were stained for 30 min at 4 °C in the dark with the following antibodies: chondrocyte (CD44-PE Vio770 clone REA690, CD73-PE clone REA804, CD90-FITC clone REA897, CD105-PerCP Vio700 clone REA794) markers, hemato/endothelial (CD31-PerCP Vio700 clone REA730, CD34-FITC clone AC136, CD45-PE Vio770 clone REA747) markers and bone marrow mesenchymal stromal cell (CD271-PE clone REA844) markers (all from Miltenyi Biotec, Bergisch Gladbach, Germany). After the cell wash with FACS buffer (phosphate buffer, 5% FBS, 0.1% sodium azide), cells were detected by flow cytometry using a CytoFLEX flow cytometer (Beckman Coulter, Fullerton, CA, USA). The following antibody combinations were used: CD73/90/105/44 and CD34/271/31/45 (FITC, PE, PC5 and PC7 channels, respectively, for both combinations).
Antibodies
Bone Marrow Stromal Cells
Buffers
CD-271
CD44 protein, human
Cells
Chondrocyte
Clone Cells
Endothelium
Flow Cytometry
Fluorescein-5-isothiocyanate
Immunoglobulins
Mesenchyma
NT5E protein, human
Phosphates
Sodium Azide
Thy-1 Antigens
Each sample was transferred to a collection tube and resuspended in PBS/1% BSA/5mM EDTA. Fluorescently tagged antibodies were added at concentrations presented in Table 3 and incubated for 30 min on ice. Labeled cells were washed three times with PBS to remove unbound antibody and resuspended in flow buffer (PBS with 2% BSA, 1 mM EDTA, and 1 μg/mL DAPI). Cells were sorted on a BD FacsAria III. LEps were defined as CD133+ /CD271− cells, and MEps were defined as CD133−/CD271+ cells, with DAPI + cells discarded. Compared to cells from standard 2-D cultures, postconfluent cells exhibit marked autofluorescence.
Antibodies
Buffers
CD-271
Cells
CTSL protein, human
DAPI
Edetic Acid
Immunoglobulins
LEP protein, human
Patient-derived GBM cells (U3034MG, U3088MG, and U3031MG)
or glioma cells (GCs) were grown in 6-well plates (50,000 cells/well),
coated with poly-l -ornithine (15 μg/mL) and laminin
(10 μg/mL), and grown to a confluency of 80%. Cells were expanded
in medium containing neurobasal, DMEM:F12 glutamax, media supplements,
and EGF and FGF (10 μg/mL, 1:1000) every 72 h. The plates were
incubated with p-HTMI (stock solution of 1 mg/mL in deionized water,
diluted 1:500) for 10 min, then incubated with Accutase for 7 min,
and resuspended in cell culture medium. Cells were spun down at 1500
rpm for 5 min. Further, they were incubated with binding buffer (BSA,
0.5 M EDTA, and PBS) (100 μL/sample) and CD133-APC (130-090-826
Mitenyi Biotec) (10 μL/sample), incubated for 10 min at 4 °C,
and washed with PBS prior to FACS analysis. Cells were incubated with
CD44 (45-0441 eBioscience) diluted in binding buffer and used at a
concentration of 1:10,000. The same antibody conditions as CD133 were
used for CD44 i.e. 100 μL of binding buffer, incubated for 10
min at 4 °C, and washed with PBS prior to FACS analysis. Cells
were also double stained for p-HTMI and CD271 (560834 BD Pharmingen),
5 μL/sample with the same antibody conditions as CD133. U-87MG
cells were expanded as previously described26 (link) and incubated with the same conditions of p-HTMI and CD133 and CD44
as described for GCs. To verify cell necrosis, lysis buffer was added
with 5 μL of PI per sample, and for cell apoptosis, cells were
incubated with 100 μL of 1X annexin V binding buffer and 5 μL
of APC annexin V per sample (561012 BD Pharmingen) and incubated for
15 min. The analysis was carried out on an FACS LSRII flow cytometer
equipped with FACSDiva software. Patient tissue collection and use
were in accordance with ethical permit EPN Uppsala 2007/353 and its
addendum Oct. 28, 2013.
or glioma cells (GCs) were grown in 6-well plates (50,000 cells/well),
coated with poly-
(10 μg/mL), and grown to a confluency of 80%. Cells were expanded
in medium containing neurobasal, DMEM:F12 glutamax, media supplements,
and EGF and FGF (10 μg/mL, 1:1000) every 72 h. The plates were
incubated with p-HTMI (stock solution of 1 mg/mL in deionized water,
diluted 1:500) for 10 min, then incubated with Accutase for 7 min,
and resuspended in cell culture medium. Cells were spun down at 1500
rpm for 5 min. Further, they were incubated with binding buffer (BSA,
0.5 M EDTA, and PBS) (100 μL/sample) and CD133-APC (130-090-826
Mitenyi Biotec) (10 μL/sample), incubated for 10 min at 4 °C,
and washed with PBS prior to FACS analysis. Cells were incubated with
CD44 (45-0441 eBioscience) diluted in binding buffer and used at a
concentration of 1:10,000. The same antibody conditions as CD133 were
used for CD44 i.e. 100 μL of binding buffer, incubated for 10
min at 4 °C, and washed with PBS prior to FACS analysis. Cells
were also double stained for p-HTMI and CD271 (560834 BD Pharmingen),
5 μL/sample with the same antibody conditions as CD133. U-87MG
cells were expanded as previously described26 (link) and incubated with the same conditions of p-HTMI and CD133 and CD44
as described for GCs. To verify cell necrosis, lysis buffer was added
with 5 μL of PI per sample, and for cell apoptosis, cells were
incubated with 100 μL of 1X annexin V binding buffer and 5 μL
of APC annexin V per sample (561012 BD Pharmingen) and incubated for
15 min. The analysis was carried out on an FACS LSRII flow cytometer
equipped with FACSDiva software. Patient tissue collection and use
were in accordance with ethical permit EPN Uppsala 2007/353 and its
addendum Oct. 28, 2013.
accutase
Annexin A5
Apoptosis
Buffers
CD-271
CD44 protein, human
Cell Culture Techniques
Cells
Culture Media
Dietary Supplements
Edetic Acid
Glioma
Immunoglobulins
Laminin
Necrosis
Patients
polyornithine
Flow cytometry was performed with LSRFortessa (Becton–Dickinson). In detail, 2 × 106 cells each were stained in three different multicolor panels, comprised of markers for HSPCs and endothelial progenitor cells (EPCs), immune cell subsets and MSCs and their precursors, followed by RBC lysis (BD Pharm Lyse™ Lysing Buffer, BD Biosciences, Heidelberg, Germany).
For detection and quantification of HSPCs and EPCs, cells were stained with 7-AAD viability dye (BioLegend, San Diego, CA, USA) and the following antibodies (all from BioLegend, unless otherwise noted): anti-CD14-APC-Cy7 (63D3), anti-CD31-Brilliant Violet 605™ (WM59), anti-CD34-Alexa Fluor® 700 (581), anti-CD45-V500 (HI30, BD Horizon™), anti-CD117-Alexa Fluor® 488 (104D2), anti-CD133-Brilliant Violet 421™ (clone 7), and anti-CD309-PE (7D4-6).
For analysis of immune cell subsets, cells were stained with 7-AAD viability dye and the following antibodies (all from BioLegend): anti-CD3-Pacific Blue (HIT3a), anti-CD4-Alexa Fluor® 700 (SK3), anti-CD8-Brilliant Violet 510™ (SK1), anti-CD11b-PE-Cy7 (LM2), anti-CD14-APC-Cy7 (63D3), anti-CD19-PE (HIB19), anti-CD45-FITC (HI30), anti-CD56-Alexa Fluor® 647 (5.1H11), anti-CD183-Brilliant Violet 605™ (G025H7), and anti-CD194-PE-Dazzle™ 594 (L291H4).
MSCs and their precursors were detected in the BM aspirates by staining with 7-AAD viability dye and the following antibodies (all from BioLegend, unless otherwise noted): anti-CD29-APC-Cy7 (TS2/16), anti-CD34-Alexa Fluor® 700 (581), anti-CD45-FITC (HI30), anti-CD73-Brilliant Violet 605™ (AD2), anti-CD90-PE-Cy7 (5E10, BD Horizon™), anti-CD105-PE-CF594 (266, BD Horizon™), anti-CD119-PE (GIR-208), anti-CD146-Brilliant Violet 510™ (P1H12), and anti-CD271-BV421 (C40-1457, BD Horizon™).
Flow cytometry data were analyzed using FCS Express 6 Flow Software (De Novo Software, Pasadena, CA, USA). The percentages of viable cells of each cell type were converted to cell count per milliliter processed BM.
For detection and quantification of HSPCs and EPCs, cells were stained with 7-AAD viability dye (BioLegend, San Diego, CA, USA) and the following antibodies (all from BioLegend, unless otherwise noted): anti-CD14-APC-Cy7 (63D3), anti-CD31-Brilliant Violet 605™ (WM59), anti-CD34-Alexa Fluor® 700 (581), anti-CD45-V500 (HI30, BD Horizon™), anti-CD117-Alexa Fluor® 488 (104D2), anti-CD133-Brilliant Violet 421™ (clone 7), and anti-CD309-PE (7D4-6).
For analysis of immune cell subsets, cells were stained with 7-AAD viability dye and the following antibodies (all from BioLegend): anti-CD3-Pacific Blue (HIT3a), anti-CD4-Alexa Fluor® 700 (SK3), anti-CD8-Brilliant Violet 510™ (SK1), anti-CD11b-PE-Cy7 (LM2), anti-CD14-APC-Cy7 (63D3), anti-CD19-PE (HIB19), anti-CD45-FITC (HI30), anti-CD56-Alexa Fluor® 647 (5.1H11), anti-CD183-Brilliant Violet 605™ (G025H7), and anti-CD194-PE-Dazzle™ 594 (L291H4).
MSCs and their precursors were detected in the BM aspirates by staining with 7-AAD viability dye and the following antibodies (all from BioLegend, unless otherwise noted): anti-CD29-APC-Cy7 (TS2/16), anti-CD34-Alexa Fluor® 700 (581), anti-CD45-FITC (HI30), anti-CD73-Brilliant Violet 605™ (AD2), anti-CD90-PE-Cy7 (5E10, BD Horizon™), anti-CD105-PE-CF594 (266, BD Horizon™), anti-CD119-PE (GIR-208), anti-CD146-Brilliant Violet 510™ (P1H12), and anti-CD271-BV421 (C40-1457, BD Horizon™).
Flow cytometry data were analyzed using FCS Express 6 Flow Software (De Novo Software, Pasadena, CA, USA). The percentages of viable cells of each cell type were converted to cell count per milliliter processed BM.
7-aminoactinomycin D
alexa fluor 488
Alexa Fluor 647
Antibodies
Buffers
CD-271
Cells
Clone Cells
CXCR3 protein, human
Endothelial Progenitor Cells
Flow Cytometry
Fluorescein-5-isothiocyanate
ITGAM protein, human
Muromonab-CD3
NT5E protein, human
Thy-1 Antigens
vascular endothelial growth factor receptor-2, human
Viola
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Bioreactors
CD-271
CD4 Positive T Lymphocytes
Cells
Electroporation
Freezing
Leukapheresis
Males
Microspheres
Nitrogen
Prodigy
Saline Solution
Sulfoxide, Dimethyl
Wolves
Top products related to «CD-271»
Sourced in United States, Germany, United Kingdom, China, Canada, Japan, Italy, France, Belgium, Switzerland, Singapore, Uruguay, Australia, Spain, Poland, India, Austria, Denmark, Netherlands, Jersey, Finland, Sweden
The FACSCalibur is a flow cytometry system designed for multi-parameter analysis of cells and other particles. It features a blue (488 nm) and a red (635 nm) laser for excitation of fluorescent dyes. The instrument is capable of detecting forward scatter, side scatter, and up to four fluorescent parameters simultaneously.
Sourced in United States, Germany, United Kingdom, China, Italy, Japan, France, Sao Tome and Principe, Canada, Macao, Spain, Switzerland, Australia, India, Israel, Belgium, Poland, Sweden, Denmark, Ireland, Hungary, Netherlands, Czechia, Brazil, Austria, Singapore, Portugal, Panama, Chile, Senegal, Morocco, Slovenia, New Zealand, Finland, Thailand, Uruguay, Argentina, Saudi Arabia, Romania, Greece, Mexico
Bovine serum albumin (BSA) is a common laboratory reagent derived from bovine blood plasma. It is a protein that serves as a stabilizer and blocking agent in various biochemical and immunological applications. BSA is widely used to maintain the activity and solubility of enzymes, proteins, and other biomolecules in experimental settings.
Sourced in United States
The CD271 is a laboratory equipment product that measures the expression of the CD271 antigen, also known as the low-affinity nerve growth factor receptor (LNGFR). It is a cell surface receptor that is involved in various cellular processes. The CD271 product provides researchers with a tool to study the expression and function of this important cell surface marker.
Sourced in Germany
CD271-PE is a fluorescent-labeled antibody used for the detection and identification of cells expressing the CD271 antigen, also known as the low-affinity nerve growth factor receptor (LNGFR) or p75 neurotrophin receptor (p75NTR). It can be used in flow cytometry applications for the analysis of cell populations.
Sourced in United Kingdom
CD271, also known as the low-affinity nerve growth factor receptor (LNGFR), is a cell surface marker that can be used to identify and isolate specific cell populations. It is a transmembrane glycoprotein that plays a role in the regulation of cell growth, survival, and differentiation. This product can be used for flow cytometry, cell sorting, and other applications where the identification and isolation of CD271-positive cells is required.
Sourced in United States, Germany, United Kingdom, France
CD73-PE is a fluorochrome-conjugated antibody that binds to the CD73 protein. CD73 is an enzyme involved in the conversion of extracellular adenosine monophosphate to adenosine. This product can be used for the identification and analysis of cells expressing CD73 using flow cytometry.
Sourced in United States, Germany, United Kingdom, China, Belgium, Italy, Australia, Switzerland, Canada, Japan, France, Denmark
The FACSAria III is a high-performance cell sorter designed for advanced flow cytometry applications. It features a robust and flexible optical system, enabling precise cell sorting and analysis. The core function of the FACSAria III is to provide users with the ability to sort and analyze complex cell samples with high accuracy and efficiency.
Sourced in Germany, United Kingdom
CD271-APC is a fluorochrome-conjugated antibody specific for the CD271 (p75 NGFR) cell surface marker. CD271 is expressed on various cell types, including nerve cells and their progenitors. The APC (allophycocyanin) fluorochrome allows for detection of CD271-positive cells using flow cytometry or other fluorescence-based applications.
Sourced in United States, Germany, United Kingdom, Japan, Belgium, China, Canada, Italy, France, South Sudan, Singapore, Australia, Denmark, Uruguay
The FACSAria II is a high-performance cell sorter produced by BD. It is designed for precision cell sorting and analysis. The system utilizes flow cytometry technology to rapidly identify and separate different cell populations within a sample.
Sourced in United States, Germany, United Kingdom, France, Canada, Belgium, Australia, Italy, Spain, Switzerland, China, Netherlands, Finland, Japan, Jersey, Lao People's Democratic Republic
FACSDiva software is a user-friendly flow cytometry analysis and data management platform. It provides intuitive tools for data acquisition, analysis, and reporting. The software enables researchers to efficiently process and interpret flow cytometry data.
More about "CD-271"
Discover the power of PubCompare.ai, the AI-driven platform that optimizes your nerve growth factor receptor (NGFR) research protocols.
Also known as CD-271, this cell surface receptor plays a crucial role in the development and survival of nerve cells, and is expressed in various tissues, including the nervous system.
It is involved in the signaling pathways that regulate neuronal differentiation, axon growth, and neuroprotection, making it an important target for research in the fields of neuroscience, neurodegenerative disorders, and regenerative medicine.
Easily locate relevant protocols from literature, pre-prints, and patents, and leverage AI-driven comparisons to identify the best approaches for your CD-271 studies.
This seamless optimization tool empowers researchers to accelerate their NGFR research and drive breakthroughs in understanding the biology and therapeutic potential of this key receptor.
Explore the FACSCalibur and FACSAria III flow cytometry systems, as well as the FACSAria II and FACSDiva software, to analyze and sort cells expressing CD271 and CD73.
Utilize bovine serum albumin (BSA) to optimize your cell staining and sorting protocols.
Experience the power of PubCompare.ai and unlock new possibilities in your CD271-related research.
Also known as CD-271, this cell surface receptor plays a crucial role in the development and survival of nerve cells, and is expressed in various tissues, including the nervous system.
It is involved in the signaling pathways that regulate neuronal differentiation, axon growth, and neuroprotection, making it an important target for research in the fields of neuroscience, neurodegenerative disorders, and regenerative medicine.
Easily locate relevant protocols from literature, pre-prints, and patents, and leverage AI-driven comparisons to identify the best approaches for your CD-271 studies.
This seamless optimization tool empowers researchers to accelerate their NGFR research and drive breakthroughs in understanding the biology and therapeutic potential of this key receptor.
Explore the FACSCalibur and FACSAria III flow cytometry systems, as well as the FACSAria II and FACSDiva software, to analyze and sort cells expressing CD271 and CD73.
Utilize bovine serum albumin (BSA) to optimize your cell staining and sorting protocols.
Experience the power of PubCompare.ai and unlock new possibilities in your CD271-related research.